GLP-1 food: start with what people actually eat
Your formula can hit its protein target while the product misses the eating occasion. Here is the question I would put at the top of the brief.
Food biotech and nutrition analysis, with evidence, commercial implications and questions for R&D teams, founders and investors.
Your formula can hit its protein target while the product misses the eating occasion. Here is the question I would put at the top of the brief.
A steady monthly burn can hide the bills that shorten your runway. Put the commitments and receipts on a calendar.
One bar is measured. The others are modelled. Make the difference visible before an investor asks.
The next generation needs sensory evidence, process capability and commercial discipline. A spending ratio alone cannot tell you who has them.
A pilot can produce useful evidence and binding commitments. Map what still separates the trial from the next buying decision.
Upstream titre is only part of the production story. Follow recovery, functionality and separation costs through to the saleable ingredient.
Prepare batch records, process limits, contamination investigations and recovery data for an external production trial.